Business Standard
Friday, Feb 17, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 
Chinese raw materials may push up common drug prices
Joe C Mathew / New Delhi April 28, 2008

Sharp increase in prices of raw materials may soon force domestic drug firms to raise prices of a majority of the commonly used medicines. The main reason is the high cost of imported drug intermediates from China, it is learnt.

All major antibiotics, which account for about 60 per cent of the Rs 35,000-crore domestic medicine sales, will become expensive if prices of these imported intermediates continue to rise, industry sources say.

Sources say the price of ciprofloxacin bulk drug, the raw material that is used to manufacture the commonly-used antibiotic, has gone up 47 per cent in just three months. "A kilogram of ciprofloxacin is costing Rs 1,400 per kg as against Rs 950 per kg three months ago," said an industry source.

Similarly, the price of azithromycin has gone up from Rs 4,300 per kg to Rs 5,900 per kg in a short span of time. Amoxycillin, another fast-selling antibiotic which now costs Rs 2,150 per kg, was available for Rs 1,450 per kg two-three months ago, they said.

India depends on Chinese imports for raw materials for common antibiotics.

"Almost 90 per cent of our bulk-drug requirement is met through imports. The increase in prices of Chinese bulk drugs has affected almost every drug segment, including vitamin E and betalactum. The closure of several bulk drug units in China due to recently-introduced environmental norms and other manufacturing specifications are the reasons for the price increase," says an industrialist.

The industry also cites withdrawal of several export incentives to Chinese firms as one of the reasons.

The companies say they are operating on thin margins due to the competitive nature of the market representing these therapeutic areas and will be compelled to go for a price hike.

Interestingly, medicine is among the few segments that have not witnessed significant price increases despite raging inflation in the country in recent months.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Wall Street opens flat as data offsets Moody's warning
- Thomas Cook India Q4 net jumps three times
- Govt plans to make 30% sourcing from MSEs mandatory
- Explain ways to cover govt loss on 3G roaming: TDSAT to telcos
- Magma Fincorp plans to start gold finance biz in H1 of FY13
  Read Business news in 
- Now property search gets more exciting than ever before!
- High Growth Business Opportunities in Africa - Register to explore
- Medium-sized businesses are the engines of a smarter planet.
- We live for our family. have you secured them?
- Office 365 for professionals and small businesses.
- Earn fuel worth Rs.2400 with Citi
- India's No. 1 Property Site. Click here to know more..
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Get 5% cashback on telephone bills with Citi
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Be part of it The World's Largest Aircraft.
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
- Health is Wealth..... Insurance + Savings... Know More...
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Marico: Stepping into unchartered territory
- Asian stocks fall as Greek bailout delay dampens mood
- Sonalde Desai: Sons of the soil
- Bhupesh Bhandari: A spectrum of disagreement
- A crown of thorns awaits winners of BMC polls
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
  Hot Searches  
 
IRFC bond |  Antrix-Devas |  Rafale fighter |  Junglee |  IPL 5 |  Dhanlaxmi Bank |  Thomas Cook |  TCS |  Sarfaesi Act |  Vodafone |  Aakash tablet |  Sodexo |  Rupee |  Samsung Galaxy Note |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  Anna Hazare |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us